QT Vascular Overview

  • Founded
  • 2005
Founded
  • Status
  • Public
  • Stock Symbol
  • 5I0
Stock Symbol
  • Investments
  • 2

QT Vascular General Information

Description

QT Vascular Ltd engages in the development and distribution of therapeutic solutions for the treatment of vascular diseases. It designs, assembles, and distributes therapeutic solutions for the minimally invasive treatment of complex vascular diseases. The firm offers coronary products, including Chocolate percutaneous transluminal coronary angioplasty (PTCA) balloon catheter to reduce vessel trauma; and Glider PTCA for the treatment of various complex lesions. It also offers Chocolate percutaneous transluminal angioplasty (PTA) balloon catheter for the treatment of blocked arteries; Chocolate Touch, a drug-coated balloon catheter; GliderfleX PTA for treating distal peripheral vessels; and GliderXtreme PTA balloon catheter that targets complex lesions in the distal peripheral vasculature.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Therapeutic Devices
Stock Exchange
SES
Primary Office
  • 3A International Business Park
  • No. 09-10/11/12 ICON IBP Tower B
  • Singapore, 609935
  • Singapore

QT Vascular Timeline

2018201920202021
Financing RoundFinancing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

QT Vascular Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$11.8M 2.24B 13.9M

QT Vascular Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 5,525 4,081 (2,148) 27,343
Revenue 3,735 7,954 11,165 14,312
EBITDA (7,888) (8,722) 30,727 (15,960)
Net Income (8,657) (9,643) 29,572 (22,871)
Total Assets 10,009 13,082 24,262 17,659
Total Debt 2,092 1,694 2,389 10,008
Public Fundamental Data provided by Morningstar, Inc. disclaimer

QT Vascular Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore QT Vascular‘s full profile, request access.

Request a free trial

QT Vascular Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
QT Vascular Ltd engages in the development and distribution of therapeutic solutions for the treatment of vascular disea
Therapeutic Devices
Singapore, Singapore
000.00
00000000000 000.00

000000 0

t esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt
00000000000 0000000
Wayne, PA
0 As of 0000
000.00
000000000 - 000.00

0000000

bore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi
00000000000 0000000
Kirkland, WA
00 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

QT Vascular Competitors (15)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cagent Vascular Venture Capital-Backed Wayne, PA 0 000.00 000000000 - 000.00
0000000 0000000000 Venture Capital-Backed Kirkland, WA 00 00000 00000000000 00000
0000000 Venture Capital-Backed Burnaby, Canada 000 00000 000000000000 00000
0000000 Corporation Richmond, Canada 000 00000 000000000 00000
00000000000 Venture Capital-Backed Marlborough, MA 00 00000 000000 - 000 00000
You’re viewing 5 of 15 competitors. Get the full list »

QT Vascular Executive Team (4)

Name Title Board Seat Contact Info
Eitan Konstantino Ph.D Co-Founder, Chief Executive Officer & Board Member
Kelvin Tong Chief Financial Officer
Maria Pizarro Executive Vice President and Vice President of Research & Development
To view QT Vascular’s complete executive team members history, request access »

QT Vascular Board Members (8)

Name Representing Role Since
0000 000000 00 Self Board Member 000 0000
00000 00000000000 00.0 QT Vascular Co-Founder, Chief Executive Officer & Board Member 000 0000
0000000 00000000 Self Board Member 000 0000
0000 000 Three Arch Partners Board Member 000 0000
000 0000 000 QT Vascular Board Member & Audit Committee Chairman 000 0000
You’re viewing 5 of 8 board members. Get the full list »

QT Vascular Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore QT Vascular‘s full profile, request access.

Request a free trial

QT Vascular Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 0 19-Dec-2018 00000 00000 00 00000 Therapeutic Devices 00000 00000000000 00.0
TriReme Medical 11-Jul-2013 Merger of Equals Surgical Devices
To view QT Vascular’s complete investments and acquisitions history, request access »